Browsers that can not handle javascript will not be able to access some features of this site.
Skip Navigation
Michigan Department of Community HealthMichigan.gov, Official Website for the State of Michigan
Michigan.gov HomeMDCH Home | Sitemap | Contact MDCH
Printer Friendly Version Printer Friendly   Text Only Version Text Version  Share this page.
Hib Vaccine (updated 1/12/11)

Agency: Community Health


CDC published  Licensure of a Haemophilus influenzae Type b (Hib) Vaccine (Hiberix) and Updated Recommendations for Use of Hib Vaccine  in the September 18, 2009, issue of MMWR. A summary is provided here; however, health care providers are advised to read the entire MMWR.

On August 19, 2009, the Food and Drug Administration (FDA) licensed Hiberix (GlaxoSmithKline Biologicals, Rixensart, Belgium), a Haemophilus influenzae type b (Hib) conjugate vaccine composed of H. influenzae type b capsular polysaccharide (polyribosyl-ribitol-phosphate [PRP]) conjugated to inactivated tetanus toxoid (PRP-T). Hiberix is licensed for use as the booster (final) dose of the Hib vaccine series for children aged 15 months through 4 years (before the 5th birthday) who have received previously the primary series of Hib vaccination (consisting of 2 or 3 doses, depending on the formulation).

The Advisory Committee on Immunization Practices (ACIP) recommends Hib booster vaccination for children at ages 12 through 15 months; however, because of the recent shortage of Hib vaccines, many children have deferred the booster dose and therefore require catch-up vaccination. Since Hib vaccine is no longer in short supply, all children can now get the Hib booster shot at age 12 through 15 months.

Vaccination recommendations in this MMWR update the previous advisory on Hib booster administration (June 26, 2009), which advised that children with deferred booster doses receive it at the next regularly scheduled visit. Vaccination providers are now recommended to begin recall of children in need of the booster dose when feasible and monovalent Hib vaccine supply in the office is adequate. Details about the indications and guidance for use of Hiberix are included in the September 18, 2010, MMWR. The updated recommendations reflect CDC's assessment of the existing national Hib vaccine supply and will be updated if the supply changes. Updated information about the national Hib vaccine supply is posted on CDC's  Current Vaccine Shortages & Delays web page.

Hib Vaccine Dose Schedule & Catch-up Immunization Schedule  (updated 1/12/11)

 

 

Michigan Business One Stop
Link to Department and Agencies Web Site Index
Link to Statewide Online Services Index
Link to Statewide Web-based Surveys
Link to RSS feeds available on this site
Related Content
 •  Vaccine Information Statements (VIS)
 •  CDC Childhood Immunization Champion Award PDF icon
 •  2012 Recommended Childhood Immunization Schedules - new!
 •  2012 Adult Immunization Schedule - new!
 •  Michigan Immunization Timely Tips (MITT) Newsletter - Feb. issue posted
 •  2012 Fall Immunization Conferences - Save the Dates!
 •  Health Care Personnel Immunization Recommendations published by ACIP (11/23/11)
 •  Quick Looks & additional resources (updated 2/9/12)
 •  Immunization Education Opportunities for Health Care Personnel
 •  MDCH Influenza (Flu) website
 •  Key Facts about Measles (6/11) PDF icon
 •  2011 AIM Provider Toolkit
 •  Healthy Camp Guidelines PDF icon
 •  Healthcare Personnel Vaccination Recommendations (3/11) PDF icon
 •  Pertussis (Whooping Cough) in Michigan
 •  MDCH Adolescent Immunization Website
 •  Helping Adults Pay for Vaccines PDF icon
 •  2011 Binational Childhood Schedule (U.S.A./Mexico) PDF icon
 •  Immunization Disparity Resources
 •  Immunization School and Childcare/Preschool Rules 2011

Michigan.gov Home | MDCH Home | Contact MDCH | State Web Sites
Privacy Policy | Link Policy | Accessibility Policy | Security Policy | Michigan News | Michigan.gov Survey

Copyright © 2001-2011 State of Michigan